The effect of coronary angiography on renal function in preemptive renal transplant candidates

Clinical Transplantation

Volumn 25, Issue 4, 2011, Pages 594-599

  Lorenz, Elizabeth C ^a   Stegall, Mark D ^a   Cosio, Fernando G ^a   Gloor, James M ^a   Larson, Timothy S ^a   Taler, Sandra J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chronic kidney disease; Clinical nephrology; Coronary artery disease; Dialysis; Kidney transplantation

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; COHORT STUDIES; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS;

EID: 80051676522     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01347.x     Document Type: Article

References (29)

1. Kasiske BL, Snyder JJ, Matas AJ et al. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 2002: 13: 1358.
2. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001: 344: 726.
3. Cosio FG, Alamir A, Yim S et al. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 1998: 53: 767.
4. Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplant candidates: clinical practice guidelines. Am J Transplant 2001: 2: S5.
5. Manske CL, Wang Y, Rector T et al. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992: 340: 998.
6. Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004: 79: 211.
7. Barrett BJ, Parfrey PS, Vavasour HM et al. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 1992: 326: 431.
8. Moore RD, Steinberg EP, Powe NR et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992: 182: 649.
9. Aspelin P, Aubry P, Fransson SG et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003: 348: 491.
10. Jo SH, Youn TJ, Koo BK et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 2006: 48: 924.
11. Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002: 105: 2259.
12. Rudnick MR, Goldfarb S, Wexler L et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995: 47: 254.
13. Mccullough PA, Wolyn R, Rocher LL et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997: 103: 368.
14. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after coronary intervention: development and initial validation. J Am Coll Cardiol 2004: 44: 1393.
15. Gruberg L, Mehran R, Dangas G et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001: 52: 409.
16. Freeman RV, O'donnell M, Share D et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002: 90: 1068.
17. Parfrey PS, Griffiths SM, Barrett BJ et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both. A prospective controlled study. N Engl J Med 1989: 320: 143.
18. Gruberg L, Mintz GS, Mehran R et al. The prognostic implications of further renal function deterioration within 48h of interventional coronary procedures in patients with pre-existent renal insufficiency. J Am Coll Cardiol 2000: 36: 1542.
19. Wang A, Holcslaw T, Bashore TM et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int 2000: 57: 1675.
20. Taliercio CP, Vlietstra RE, Fisher LD et al. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986: 104: 501.
21. Barrett BJ, Parfrey PS, Vavasour HM et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992: 41: 1274.
22. Manske CL, Sprafka JM, Strony JT et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990: 89: 615.
23. Gruberg L, Dangas G, Mehran R et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 2002: 55: 66.
24. Kumar N, Dahri L, Brown W et al. Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease. Clin J Am Soc Nephrol 2009: 4: 1907.
25. Pellikka PA, Roger VL, Oh JK et al. Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 1995: 70: 16.
26. Kasiske BL, Guijarro C, Massy GA et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996: 7: 158.
27. Pilmore H. Cardiac assessment for renal transplantation. Am J Transplant 2006: 6: 659.
28. De Lima JJG, Sabbaga E, Vieira MLC et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 2003: 42: 263.
29. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006: 239: 392.